Laviana Pharma (Tianjin) Co., Ltd.

Founded in January 2014, Laviana Pharma (Tianjin) Co., Ltd. ( “Laviana Tianjin”) is a cGMP-compliant R&D center with kilogram-level R&D capability established by Laviana Pharma to adjust the business structure and further expand the corporate industrial chain to the downstream GMP production. Our main service scope covers R&D, technical consulting and services for pharmaceutical products such as pharmaceutical APIs, intermediates, formulations, and new drug development. Situated at Building A4, Low Carbon Industrial Base, Huaming Hi-tech Industrial Zone, Dongli District, Tianjin, Laviana (Tianjin) covers a floor area of 12,736.02 square meters, and has built more than twenty modern chemical synthesis laboratories, 120 fume hoods, 1,500 square meters of analytical laboratories, three kilogram-level laboratories with kilogram-level experimental production capabilities. We have 6 cGMP production lines for preclinical researches and clinical Phase I & Phase II API synthesis and a process safety assessment laboratory. Moreover, we carry out process validation, data collection and other pilot test R&D related work to provide the necessary R&D support for the development of product processes suitable for future mass production, and have 2 additional high potency API production lines and 2 formulation GMP laboratories under construction.

Laviana has completed and helped our clients with dozen’s of IND and NDA submissions for Class I small molecule chemical drugs and APIs, clinical Phase I & Phase II API synthesis services, and thousands of preclinical researches and process optimization projects.